Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00593372 · ClinicalTrials.gov registry record · Phase 1

Treatment of Language and Memory in Patients With Alzheimer's Disease

A Phase 1 study of Alzheimer Disease, sponsored by University of Arkansas.

Completed
Registry status
Phase 1
Development phase
11
Enrollment target
1
Study location

NCT00593372 is a Phase 1 study of Alzheimer Disease that has completed, run by University of Arkansas. The registered enrollment target is 11 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00593372, a Phase 1 study of Alzheimer Disease, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
Phase 1
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect data on the effects of behavioral interventions for memory and communication deficits in persons taking cholinesterase inhibitors compared with the effects of cholinesterase inhibitors alone. Initial testing will include a written case history, tests of communication skills, and interviews with the participants, family, and staff caregivers to help select potential goals for treatment. Participants will be randomly selected to participate in Group A (control) or Group B (intervention). Group A will use a Caregiver Checklist for eight weeks to identify any increase or decrease in the occurrence of the identified communication deficits. Group B will have 16 treatment sessions by a Speech Language Pathologist during the eight-week period. A post test will be administered to all participants.

Conditions Studied

Alzheimer Disease

Interventions

  • BEHAVIORAL Spaced Retrieval Training

Study Locations (1)

Arkansas

  • UAMS Medical Center - Little Rock

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2003-08
Est. Completion 2010-04
Phase Phase 1

Sponsor

University of Arkansas

318 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00593372

The ClinicalTrials.gov registry entry for NCT00593372 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Spaced Retrieval Training is the first listed.

NCT00593372 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT00593372 about?

NCT00593372 is a clinical study titled "Treatment of Language and Memory in Patients With Alzheimer's Disease". The purpose of this study is to collect data on the effects of behavioral interventions for memory and communication deficits in persons taking cholinesterase inhibitors compared with the effects of cholinesterase inhibitors alone. Initial testing will include a written case history, tests of commun...

What is the current status of trial NCT00593372?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2003-08. Estimated completion is 2010-04.

What conditions does trial NCT00593372 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT00593372?

The interventions under investigation include: Spaced Retrieval Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00593372?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00593372 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.